Update on Tuberculosis/HIV Coinfections: Across the Spectrum From Latent Infection Through Drug-Susceptible and Drug-Resistant Disease.Published in:Topics in Antiviral Medicine, 2022, v. 30, n. 2, p. 464By:Ignatius, Elisa H.;Swindells, SusanPublication type:Article
Addressing Depressive Disorders Among People With HIV.Published in:Topics in Antiviral Medicine, 2022, v. 30, n. 2, p. 454By:Fuenmayor, Andres;Cournos, FrancinePublication type:Article
CROI 2022: Summary of Basic Science Research in HIV and SARS-CoV-2.Published in:Topics in Antiviral Medicine, 2022, v. 30, n. 2, p. 419By:Stevenson, MarioPublication type:Article
CROI 2022: Epidemiologic Trends and Prevention for HIV and SARS-CoV-2.Published in:Topics in Antiviral Medicine, 2022, v. 30, n. 2, p. 426By:Buchbinder, Susan;Liu, AlbertPublication type:Article